Vector BioPharma

Vector BioPharma is a biopharmaceutical company aimed at transforming the safety, efficacy, and specificity of drug delivery to improve patient treatment. Vector BioPharma utilizes cutting-edge platform technology from world-class academic research at the University of Zurich, employing engineered adenovirus vectors to achieve cell- and tissue-specific delivery, with tunable expression of genes and regulators with unprecedented precision. We use our proprietary platform to develop next-generation therapies that deliver the right gene to the right place at the right time with unparalleled accuracy and versatility.